• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Special Reports
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Resources
    • About MassDevice
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
    • In-Depth Coverage
    • Latest News
  • Attend DeviceTalks
    • Events
      • DeviceTalks Minnesota – May 4
      • DeviceTalks Boston – May 27–28
      • DeviceTalks West
      • DeviceTalks Tuesdays
    • DeviceTalks Podcast Network
      • DeviceTalks Weekly
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Advertise
  • Subscribe
Home » Smith+Nephew unveils expanded enterprise strategy for ASCs

Smith+Nephew unveils expanded enterprise strategy for ASCs

July 21, 2026 By Sean Whooley

Smith+Nephew ASC Solutions ambulatory surgery centerSmith+Nephew (NYSE:SNN) today announced the launch of ASC Solutions, an expanded enterprise strategy for ambulatory surgery centers (ASCs).

The London-based orthopedic giant wants to take a customer-centric approach to help ASC customers realize their key objectives of cost optimization, quality and outcome performance.

ASCs represent a fast-growing outpatient care approach. Smith+Nephew’s work in the space continues, as it announced work to support the first UK-based ASC last year. Other orthopedic leaders, including Zimmer Biomet and Stryker, are also pursuing advances in the ASC.

Smith+Nephew’s ASC Solutions helps customers source best-in-class expertise, differentiated procedural technologies and advanced data and analytics. It aims to help ASCs accelerate growth, improve operational performance, and drive patient outcomes.

The company said this expands its ASC ONE delivery model into an integrated platform. It aims to simplify ASC development, accelerate facility readiness and support long-term operational success. The platform brings together Smith+Nephew partners to support development planning, facility design and construction, operating company formation, financing, sterile processing, information technology infrastructure, and clinical enablement within a coordinated framework.

ASC ONE delivers a streamlined approach through a single point of coordination within the strategic network. To support this, the company has a streamlined enterprise operating model to support ASC customers. It said its enterprise partnerships, innovative technologies and integrated service offerings continue to help customers improve access, enhance performance and create sustainable healthcare value.

Commentary from Smith+Nephew leadership and doctors

Bryan Grossman, SVP, Healthcare Solutions and Channel Management at Smith+Nephew, said:

“ASC Solutions enables our customers to leverage Smith+Nephew’s strategic alliances with key partners that help drive strategic growth. By combining the strength of our industry-leading products and services with our partner networks and expertise in clinical, operational, and business performance, we help customers build stronger organizations, expand access to care and succeed in an increasingly complex healthcare environment.”

Dr. Jeffrey Racca of New Mexico Orthopaedics said:

“In today’s environment, Smith+Nephew is bringing independent physician practices a real opportunity to continue capitalizing on ancillaries, with the ability for physicians to own 100% of the equity in their center. Between the team they’ve assembled to bring these projects to market and the strength of their product portfolio behind it, this is something that’s truly differentiating in today’s environment.”

Filed Under: Business/Financial News, Hospital Care, Orthopedics Tagged With: ambulatory surgery centers (ASCs), Smith+Nephew

More recent news

  • Zimmer Biomet, Think Surgical extend exclusive distribution agreement
  • Cambridge Heartwear inks £184M deal to supply NHS with portable ECG monitors
  • J&J, Smith+Nephew plans for ortho megamerger reportedly fall through
  • California and Massachusetts still reign as top US medtech headquarters locations
  • Teleflex wins Breakthrough Device designation for Freesolve resorbable scaffold

About Sean Whooley

Sean Whooley is a senior editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at [email protected].

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >
MDO ad
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2026 · Arrowfly LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy